MicroRNA-221 is a potential biomarker of myocardial hypertrophy and fibrosis in hypertrophic obstructive cardiomyopathy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-221 is a potential biomarker of myocardial hypertrophy and fibrosis in hypertrophic obstructive cardiomyopathy
Authors
Keywords
-
Journal
BIOSCIENCE REPORTS
Volume 40, Issue 1, Pages -
Publisher
Portland Press Ltd.
Online
2020-01-10
DOI
10.1042/bsr20191234
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- microRNA-21 and hypertension
- (2018) Xiao Li et al. HYPERTENSION RESEARCH
- miR-21 promotes cardiac fibroblast-to-myofibroblast transformation and myocardial fibrosis by targeting Jagged1
- (2018) Xue-liang Zhou et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload–Induced Heart FailureNovelty and Significance
- (2017) Robin Verjans et al. HYPERTENSION
- Inhibition of microRNA-155 ameliorates cardiac fibrosis in the process of angiotensin II-induced cardiac remodeling
- (2017) Yuzhen Wei et al. Molecular Medicine Reports
- MicroRNA-221-3p Plays an Oncogenic Role in Gastric Carcinoma by Inhibiting PTEN Expression
- (2017) Jianping Shi et al. ONCOLOGY RESEARCH
- MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension
- (2017) Xiaowei Nie et al. VASCULAR PHARMACOLOGY
- MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure
- (2017) Javier Beaumont et al. Scientific Reports
- Crucial Role of miR-433 in Regulating Cardiac Fibrosis
- (2016) Lichan Tao et al. Theranostics
- Targeting of Gamma-Glutamyl-Cysteine Ligase by miR-433 Reduces Glutathione Biosynthesis and Promotes TGF-β-Dependent Fibrogenesis
- (2015) Cristina Espinosa-Diez et al. ANTIOXIDANTS & REDOX SIGNALING
- SOX6 and PDCD4 enhance cardiomyocyte apoptosis through LPS-induced miR-499 inhibition
- (2015) Zhuqing Jia et al. APOPTOSIS
- miR-222 Is Necessary for Exercise-Induced Cardiac Growth and Protects against Pathological Cardiac Remodeling
- (2015) Xiaojun Liu et al. Cell Metabolism
- Noncoding RNAs as regulators of cardiomyocyte proliferation and death
- (2015) Maria-Teresa Piccoli et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy
- (2015) Lu Fang et al. Journal of Translational Medicine
- microRNA-222 modulates liver fibrosis in a murine model of biliary atresia
- (2014) Wen-jun Shen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNA-221 inhibits autophagy and promotes heart failure by modulating the p27/CDK2/mTOR axis
- (2014) M Su et al. CELL DEATH AND DIFFERENTIATION
- Ets-1 Targeted by MicroRNA-221 Regulates Angiotensin II-Induced Renal Fibroblast Activation and Fibrosis
- (2014) Jia Di et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Fibrosis: ultimate and proximate causes
- (2014) Victor J. Thannickal et al. JOURNAL OF CLINICAL INVESTIGATION
- Circulating Level of miR-378 Predicts Left Ventricular Hypertrophy in Patients with Aortic Stenosis
- (2014) Zhongxiu Chen et al. PLoS One
- MiR-21 Simultaneously Regulates ERK1 Signaling in HSC Activation and Hepatocyte EMT in Hepatic Fibrosis
- (2014) Juan Zhao et al. PLoS One
- Usefulness of High-Sensitivity Cardiac Troponin T and Brain Natriuretic Peptide as Biomarkers of Myocardial Fibrosis in Patients With Hypertrophic Cardiomyopathy
- (2013) Tatsuya Kawasaki et al. AMERICAN JOURNAL OF CARDIOLOGY
- Epigenetic Regulation ofmiR-17∼92Contributes to the Pathogenesis of Pulmonary Fibrosis
- (2013) Duaa Dakhlallah et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- mir-17–92 Cluster Is Required for and Sufficient to Induce Cardiomyocyte Proliferation in Postnatal and Adult Hearts
- (2013) Jinghai Chen et al. CIRCULATION RESEARCH
- Circulating miR-29a, Among Other Up-Regulated MicroRNAs, Is the Only Biomarker for Both Hypertrophy and Fibrosis in Patients With Hypertrophic Cardiomyopathy
- (2013) Roberta Roncarati et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway
- (2013) Rong Li et al. KIDNEY INTERNATIONAL
- MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis
- (2012) Tomohiro Ogawa et al. GUT
- MiR-221 promotes cardiac hypertrophy in vitro through the modulation of p27 expression
- (2012) Changxin Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure
- (2011) Geert C. van Almen et al. AGING CELL
- Small changes can make a big difference — MicroRNA regulation of cardiac hypertrophy
- (2011) Monika M. Gladka et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary
- (2011) Bernard J. Gersh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans
- (2010) Guo-Kun Wang et al. EUROPEAN HEART JOURNAL
- miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis
- (2010) Gang Liu et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started